ContraFect Corporation Announces Issuance of Patent for Novel Approach to Treat Influenza Using Inhaled Antibodies YONKERS, NY--(Marketwired - August 03, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...

ContraFect Reports Third Quarter 2016 Financial Results and Provides Business Update YONKERS, NY--(Marketwired - November 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...

ContraFect Announces Second Quarter 2016 Results YONKERS, NY --(Marketwired - August 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...

ContraFect to Present at 18th Annual BIO CEO and Investor Conference YONKERS, NY--(Marketwired - February 02, 2016) - ContraFect Corporation  (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and...